5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 29.83▼ | 29.99▼ | 29.73▲ | 27.24▲ | 24.15▲ |
MA10 | 30.01▼ | 29.71▲ | 29.11▲ | 26.90▲ | 19.66▲ |
MA20 | 30.13▼ | 28.97▲ | 27.87▲ | 24.67▲ | 15.96▲ |
MA50 | 29.74▲ | 27.21▲ | 26.92▲ | 18.99▲ | 15.59▲ |
MA100 | 29.00▲ | 26.95▲ | 26.03▲ | 15.35▲ | N/A |
MA200 | 27.74▲ | 25.93▲ | 21.93▲ | 14.20▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.116▼ | 0.033▲ | 0.230▲ | 0.066▲ | 1.870▲ |
RSI | 47.158▼ | 64.055▲ | 67.821▲ | 66.408▲ | 74.546▲ |
STOCH | 38.297 | 74.681 | 82.226▲ | 66.277 | 53.098 |
WILL %R | -54.248 | -28.231 | -20.195▲ | -11.266▲ | -40.261 |
CCI | -145.281▼ | 51.674 | 81.580 | 177.631▲ | 132.114▲ |
Tuesday, September 30, 2025 09:11 AM
Rapport Therapeutics, Inc. (NASDAQ:RAPP) is among the best fast money stocks to buy now. Analysts at JMP Securities have reaffirmed their ‘Market Outperform’ rating on Rapport Therapeutics, Inc.
|
Tuesday, September 16, 2025 11:28 AM
Rapport Therapeutics (RAPP) stock gains as Truist assigns the company a new Buy recommendation based on potential of its lead antiseizure drug. Read more here.
|
Friday, September 12, 2025 07:31 AM
Rapport Therapeutics (NASDAQ:RAPP) traded higher on Friday after Goldman Sachs assigned the neurology drug developer a Buy rating and a 12-month price target of $51 based on mid-stage trial data the ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 27.97 | 30.67 | 27.381 | 29.70 | 812,521 |
29/09/25 | 26.84 | 28.405 | 26.33 | 27.97 | 836,947 |
26/09/25 | 24.92 | 26.675 | 24.60 | 26.59 | 1,130,900 |
25/09/25 | 26.49 | 26.82 | 24.65 | 24.97 | 621,100 |
24/09/25 | 26.55 | 27.655 | 25.759 | 26.96 | 670,500 |
23/09/25 | 26.21 | 27.94 | 26.055 | 26.65 | 498,665 |
22/09/25 | 26.25 | 26.915 | 25.55 | 26.11 | 417,400 |
19/09/25 | 27.065 | 28.5165 | 26.25 | 26.36 | 1,314,559 |
18/09/25 | 26.05 | 27.39 | 25.96 | 27.35 | 432,300 |
17/09/25 | 25.83 | 27.25 | 25.65 | 26.30 | 766,100 |
|
|
||||
|
|
||||
|
|